INSTITUTE OF CELLULAR THERAPIES

 

 

 DENVAXTM

DENDRITIC CELL THERAPY

Customized Cell-based Cancer Immunotherapy 

  

INSTITUTE OF CELLULAR THERAPIES PVT.LTD.
J-3
Sector 41
Noida, UP 201303
India

ph: 91-120-2500111
fax: 91-120-4317902
alt: 91-120-2500195

info@dendriticcellresearch.com

Twitter

  • HOME
    • DISCOVERY OF DENDRITIC CELLS
  • DENVAX
  • DENVAX PROTOCOL
  • DENVAX FAQs
  • PATIENT INFORMATION
  • SUCCESS STORIES
  • PUBLICATIONS
  • CLINICAL TRIAL RESULT
  • ABOUT US
  • CONTACT US
    • ANTAH HEALTHCARE, MALAYSIA
  • PREVENTIVE VACCINE
    • ADULT STEM CELL TRANSPLANT

PREVENTIVE VACCINE

The Institute of Cellular Therapies is offering a treatment plan for preventing cancer to people who are:

 A) Positive for a Gene Mutation Test

 B) Positive for Familial Cancer Gene

 C) Have a strong family history of caner, wherein a number of family members have/are suffering from one or the other cancer type.

 For more information, contact:

jamal@dendriticcellresearch.com

Mobile: 9910055863

 

What are Familial Cancers?

Some cancers run in families. About 10% of cancers are hereditary in nature. Examples are cancer of the breast, ovaries, colon, prostate, etc.. Here Many people have relatives who have had cancer, but most of the time this is due to chance or environmental factors. In a familial cancer syndrome, an inherited genetic mutation causes a person to be at increased risk for cancer and other physical symptoms. There are many different familial cancer syndromes, and each one has a specific set of characteristic cancers and physical symptoms associated with it. For example, BRCA1 and BRCA2 gene mutations are associated with an increased risk for breast and ovarian cancer. Examples of other familial cancer syndromes include von Hippel-Lindau syndrome,Peutz-Jeghers syndrome, and Li-Fraumeni syndrome. 

Following are the features of hereditary cancers:

 

  • Two or more close relatives with the same type of cancer (on the same side of the family).
  • Cancer diagnosed at an earlier age than usual.
  • Cancer diagnosed more than once in the same person (more than one primary cancer, not a cancer recurrence).
  • Cluster of cancers associated with a known familial cancer syndrome (such as breast and ovarian).
  • Many cases of cancer in a family, more than can be accounted for by chance.
  • Cancer in a person who also has birth defects.
  • Evidence of autosomal dominant inheritance, which is when a gene from one parent overrides that of the other parent. When one parent has a dominant abnormal gene, offspring each have a 50% chance of inheriting that gene.

 GENE MUTATION TESTS

Inherited mutations in other genes increase the risk of breast and/or ovarian tumors

 Mutations in several genes, including TP53, PTEN, STK11/LKB1, CDH1, CHEK2, ATM, MLH1, and MSH2, have been associated with hereditary cancers.

  Copyright Institute of Cellular Therapies Pvt. Ltd.

All rights reserved.

Last updated on 19 October, 2011

 

 

 

 

 

 

 

 

 

 

INSTITUTE OF CELLULAR THERAPIES PVT.LTD.
J-3
Sector 41
Noida, UP 201303
India

ph: 91-120-2500111
fax: 91-120-4317902
alt: 91-120-2500195

info@dendriticcellresearch.com

Twitter